Oakland, CA, United States of America

Daniel B Mirel

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Roche Molecular Systems, Inc.. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daniel B Mirel. Retrieved from https://idiyas.com/inventor/daniel-b-mirel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Daniel B Mirel

Introduction

Daniel B Mirel is an accomplished inventor based in Oakland, CA (US). He has made significant contributions to the field of genetics and autoimmune diseases. His work focuses on understanding the genetic factors that contribute to conditions such as type 1 diabetes.

Latest Patents

Mirel holds a patent titled "Association of polymorphisms in IL4-related genes with autoimmune disease." This invention provides methods and reagents for determining sequence variants present at the IL4 receptor, IL-4, and IL-13 loci. These advancements facilitate the identification of individuals at risk for type 1 diabetes. He has 1 patent to his name.

Career Highlights

Throughout his career, Daniel B Mirel has worked with notable companies, including Roche Molecular Systems, Inc. and Teodorica L. Bugawan. His experience in these organizations has allowed him to develop innovative solutions in the field of molecular genetics.

Collaborations

Mirel has collaborated with esteemed colleagues such as Henry A Erlich and Teodorica L Bugawan. These partnerships have contributed to the advancement of research in autoimmune diseases and genetic testing.

Conclusion

Daniel B Mirel's contributions to the field of genetics and his innovative patent highlight his commitment to advancing medical science. His work continues to impact the understanding of autoimmune diseases and the identification of at-risk individuals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…